Advocacy

Fight the Fakes International Meeting

Brussels, Belgium
October 23-25, 2017

ASOP Global’s Mike Isles was among the Fight the Fakes partners representing healthcare professionals, academia, NGOs, the generic and research-based pharmaceutical industry, healthcare distributors, and consumer protection organizations who met in Brussels to work on their future plans to raise awareness of the widespread sale and use of falsified medicines across the world and the dangers associated with these fake products.

2017 Global Patient Safety Champions Reception

Washington, DC
October 11, 2017

ASOP Global’s Executive Director, Libby Baney, presented the 2017 Global Patient Safety Champion Awards to the Honorable Michael C. Burgess, MD (R-TX-26), Chairman, House Energy and Commerce Subcommittee on Health; the Honorable Eugene Green (D-TX-29), Ranking Member, House Energy and Commerce Subcommittee on Health and the National Association of Boards of Pharmacy (NABP) at a Capitol Hill reception in Washington, DC.


Libby Baney and the Honorable Eugene Green
(D-TX-29)


Libby Baney and Marty Allain, NABP


Libby Baney and the Honorable Michael C. Burgess, MD (R-TX-26)

2017 Special 301 Out-of-Cycle Review of Notorious Markets

ASOP Global’s Submitted Comments
October 2, 2017
 

The Office of the U.S. Trade Representative (USTR) annually releases its Special 301 Report on the adequacy and effectiveness of IP rights protection by U.S. trading partners. Conducted under the auspices of the Special 301 program, the 2017 Notorious Markets List identifies online and physical marketplaces that reportedly engage in and facilitate substantial copyright piracy and trademark counterfeiting. ASOP Global submitted comments in response to USTR’s request for “examples of online and physical notorious markets, including foreign trade zones that allegedly facilitate substantial trademark counterfeiting and copyright piracy.” 

Best Practice Sharing Workshop

June 29, 2017
Paris, France

The Alliance for Safe Online Pharmacies (ASOP Global) and the Alliance for Safe Online Pharmacy (ASOP EU) hosted the fifth Best Practice Sharing Workshop in Paris, France on June 29. ASOP Global’s Executive Director, Libby Baney, ASOP EU’s Mike Isles and Klaus Gritschneder, and NABP’s Policy and Communications Director, Melissa Madigan were joined by 20 EU member states and not-for-profit organizations where they discussed the need for more public awareness programs about falsified medicines like those previously conducted by ASOP Global in the U.S. and ASOP EU, as well as the “Common Logo”, which must appear on every online pharmacy selling medicine in Europe, and the latest progress relating to NABP’s .pharmacy top level domain (TLD) initiative. 

Read the News Release

Left to Right – 

Hanne Hanken (Norway); Quentin Duteil (Fondation Chirac); Monika Macisowicz (Poland); Marion Barreau (IRACM); Klaus Gritschneder (ASOP EU); Mike Isles (ASOP EU); Lynda Scammell (UK); Sammy Kohli (Denmark); Sasa Polovic (Croatia); Melissa Madigan (NABP); Alain Denis (Belgium); Philippe de Buck (Belgium); Libby Baney (ASOP Global); Felicia Vaz (Fight the Fakes); Paul Brewer (UK); Aline Plancon (FMEDs Programme)

Global Health: Access to Safe Medicines Panel

2017 European Association of Clinical Pharmacology and Therapeutics Congress (EACPT)
June 26, 2017
Prague, Czech Republic

Mike Isles, executive director of ASOP EU, and other international experts led the Global Health/Access to Safe Medicines Session during the 2017 European Association of Clinical Pharmacology and Therapeutics (EACPT) Congress, which was held in Prague from June 24-27. Watch the panel discussion featuring the experts listed below.

Pavle Zelic, Medicines and Medical Devices Agency, Serbia

Josez Glasa, Slovak Medical University, Slovakia

Mike Isles, ASOP EU and EAASM

Prof. Donald Singer, Clinical Pharmacologist, EACPT

and President, Fellowship of Postgraduate Medicine 

Canadian Online Pharmacies Forum

June 5, 2017
Quebec City, Canada

ASOP Global’s Executive Director, Libby Baney, NABP Senior Program Director, Marty Allain, NABP .pharmacy Canadian Consultant, Ronald F. Guse, and Perry Eisenschmid, CEO of the Canadian Pharmacists Association (CPhA) hosted the Canadian Online Pharmacies Forum during the 2017 Canadian Pharmacists Conference, which was co-sponsored by CPhA and the Association of Faculties of Pharmacy of Canada (AFPC) from June 2-5 in Quebec City. More than 700 pharmacists and pharmacy stakeholders attended the conference where they discussed key issues facing Canada’s healthcare system, including the opioid crisis, mental healthcare and antimicrobial stewardship.

ASOP Global Logo

 

ASOP Global/NABP Canadian Internet Sales Roundtable

May 20, 2017
Orlando, FL

ASOP Global’s Executive Director, Libby Baney, and NABP’s Policy and Communications Director, Melissa Madigan and Ronald F.Guse, an NABP .pharmacy Canadian consultant, member of the board of the Canadian Patient Safety Institute and former Manitoba Provincial Regulator were the speakers at the first Canadian Internet Drug Sales Roundtable, which was held during NABP’s 113th annual conference in Orlando, FL.

 

ASOP Global Logo

Tell Congress To Keep Our Medicines Safe

Congress is set to consider new legislation that would legalize importation of prescription medicines from foreign countries outside the jurisdiction of the U.S. Food and Drug Administration (FDA). Such a policy would put Americans at increased risk of receiving counterfeit or otherwise unsafe medications, including controlled substances offered by illegal foreign online pharmacies without a prescription, contributing to the opioid epidemic in the U.S.

The Security of the Drug Supply Chain, Patient Safety and Drug Importation

April 28, 2017
ASOP Global and The Pew Charitable Trusts held a briefing on Capitol Hill to discuss illegal online pharmacies; protections provided by the Drug Supply Chain Security Act; risks associated with legalizing importation of prescription medicines from Canada and other countries; and consequences for patients who are exposed to unsafe products.